Company to Host Conference Call and Webcast on Wednesday, November 8, 2023 LOS ANGELES, Nov. 1, 2023 /PRNewswire/ — Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined…
